Methodology The study included a random nationwide sample (n=655) of patients treated with branded semaglutide (Wegovy or Ozempic) through Ro's platform who persisted with treatment and reported their weight at 68 weeks (14 days)
In this article, well compare the benefits, mechanisms, dosing, and side effects of these medicationshelping you understand how they work and which one might be the right option for your weight loss journey
Susan Wolver, M.D., medical director of the VCU Health Medical Weight Loss Program, has been prescribing GLP-1 receptor agonists since they were first approved by the U.S
The timeline is different too
To be considered for treatment, clients must meet at least one of the following criteria: A BMI of over 30kg/m A BMI of over 27kg/m with at least one weight-related condition, which includes: Type 2 diabetes Hypertension High cholesterol Who should NOT take Semaglutide
However, most patients opt to do injections at-home to save themselves the extra office visits